About
Professor Eske Derks is Professor of Psychiatric Genetics and Group Leader of the Translational Neurogenomics Laboratory and as such plays an important role in identifying gene mechanisms that increase the risk of mental health disorders. The overarching objective of her research is to understand the downstream molecular consequences underlying statistical associations as this will be essential for translating genetic findings into the clinic. Professor Derks has a highly recognised international reputation in psychiatric genetics. She obtained her PhD in behaviour genetics at the Free University Amsterdam. Her research program investigates biological mechanisms underlying neuropsychiatric disease by investigating the impact of genetic risk factors on gene expression. She was the first to integrate genetic and transcriptomic data from 13 brain tissues to improve the functional interpretation of genetic findings for five psychiatric disorders (Nature Genetics, in press, senior author) and other complex traits (Nature Genetics, 2018). As co-PI of the International Cannabis Consortium (ICC), she has led three large meta-analyses on the genetics of cannabis use; the latest initiative included 184,765 subjects and revealed 35 genes associated with cannabis use. She is a member of the executive board of the OCD group of the Psychiatric Genomics Consortium (PGC). Professor Derks has published in highly influential journals, including Science, Nature Genetics, and Molecular Psychiatry.
Area of Interest
• Genetics • eQTL analysis • Mental health disorders • Schizophrenia • Substance use disorders (including cannabis, alcohol, smoking, and cocaine) • Genome-Wide Association • Exome chip analyses